Robin Vora is an Ophthalmology physician affiliated with Kaiser Permanente. OpenAlex indexes 68 publications with 692 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
275 W Macarthur Blvd
Oakland, CA 946115641
Telephone
510-752-1000Registry record last updated 13 Dec 2021.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year202532 payments$42,396openpaymentsdata.cms.gov ↗
- Astellas Pharma US IncProgram year202519 payments$29,340openpaymentsdata.cms.gov ↗
- Apellis Pharmaceuticals, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
76.9%Carbonic Anhydrase Inhibitor40.8%Dorzolamide-Timolol100%Part D≥19 patientsProstaglandin Analog23.8%Latanoprost100%Part D≥13 patients+ 1 more class in this area
Cancer & immunology
14.6%Calcineurin inhibitor14.6%Cyclosporine100%Part D<11 patientsCardiovascular
8.5%Beta blocker8.5%Timolol Maleate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A telemedicine-enabled intravenous thrombolytic treatment pathway for patients with hyperacute non-arteritic central retinal artery occlusion
American Journal of Ophthalmology Case Reports
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Presti, MD
Kaiser Permanente
Walter Kinney, MD
Kaiser Permanente
Alexander Flint, MD, PhD
Kaiser Permanente
Jonathan Zaroff, MD
Kaiser Permanente
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”